Shufflex Biomed is a biotechnology start-up company developing rapid diagnostic testing kits for detection and simultaneous identification of infectious pathogens. The Shufflex diagnostics method is based on a unique proprietary multiplex technology that is designed to produce test results in less than an hour, while identifying and distinguishing multiple or co-infections at the same time.
Founded in 2015, Shufflex Biomed is headquartered in Germantown, Maryland, about 30 miles from Washington, DC and also based in Lower Johnsonville in Monrovia, Liberia, West Africa.
Applying excellent science to diagnostics, Shufflex Biomed aims to produce accurate, affordable, and simple-to-use molecular diagnostic testing kits for infectious diseases in developed as well as resource-limited countries, thus saving humanity through pathogen diagnostics.
Founded in 2015, Shufflex Biomed is headquartered in Germantown, Maryland, about 30 miles from Washington, DC and also based in Lower Johnsonville in Monrovia, Liberia, West Africa.
Inventor, Multiplex Pathogen Diagnostic Test